Patent ID: 7790203

Claim:
An orally ingested composition for the treatment of herpetic epidermal lesions caused by Herpes Simplex Virus (HSV-1), Herpes Zoster, and Herpes Genitalia, consisting essentially of: a) from 30 to 50 mg of zinc sulfate, b) from 5 to 25 mg of magnesium sulfate; c) from 15 to 60 mg of thiamin; d) from 15 to 30 mg of riboflavin; e) from about 4 to 12 mg of pyridoxine hydrochloride; f) from about 300 to 1000 mg of ascorbic acid; g) from 100 to 300 mg of niacin; and h) from about 20 to 70 mg of pantothenic acid; wherein said composition is in the form of tablets or capsules.